{
  "image_filename": "table_p5_det_4_007.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_007.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_007",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table presenting vaccine effectiveness (VE) percentages (with 95% confidence intervals) for various influenza vaccines\u2014recombinant quadrivalent influenza vaccine (RIV4), standard dose quadrivalent influenza vaccine (SD-IIV4), and RIV4 combined with high-dose IIV4 plus adjuvanted IIV (Adj-IV)\u2014compared to no vaccination, stratified by age groups (18\u201364 years and \u226565 years) and by sex subgroups. does not support the claim because the table only shows comparative VE data and does not discuss production processes, mutations in cell- or egg-based vaccines, or their effect on vaccine effectiveness.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table presenting vaccine effectiveness (VE) percentages (with 95% confidence intervals) for various influenza vaccines\u2014recombinant quadrivalent influenza vaccine (RIV4), standard dose quadrivalent influenza vaccine (SD-IIV4), and RIV4 combined with high-dose IIV4 plus adjuvanted IIV (Adj-IV)\u2014compared to no vaccination, stratified by age groups (18\u201364 years and \u226565 years) and by sex subgroups.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only shows comparative VE data and does not discuss production processes, mutations in cell- or egg-based vaccines, or their effect on vaccine effectiveness.",
    "confidence_notes": null
  }
}